BRAF and breast carcinoma: Additionally, breast cancer patient tumors with high LMW-E expression also expressed high levels of b-Raf, pMEK1/2 (S217), ERK2, mTOR, and eIF4E and a low level of pAkt (T308) (Table 3 and Figure S3).